NB
Neurocrine Biosciences Inc.
NBIX · Neurocrine Biosciences Inc. · Healthcare
Up next day
3/12
25%
Fell despite growth
7/12
Good earnings ignored
Avg earnings move
±6.4%
typical swing on earnings
Price when beating
-2.1%
avg over 7 beats
Biggest single move
-18.5%
'24.12 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Even strong results barely move the stock
Up the next day 2 of 7 beats (29%)
Moves in line with results — fairly predictable
Avg -2.1% on a beat, -5.2% on a miss
Tends to keep drifting the same way for days
Day-one direction continued · 67% of last 12
vs Healthcare sector avg (153 peers)
This
-3.4%
Sector
+0.5%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
The number and guidance move the price about equally
Moved opposite to results 6 of last 12 times (50%)
5xBeat but fell
Even a beat sells off if guidance disappoints
1xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Oct 28After close
'26.9 expectedEst. EPS $2.72
Quarter ended 6/2026
Reported 2026-07-30
Next-day move
-10.1%
After 5 days -13.8%
vs Consensus$1.96→$2.85+45.4% beat
Beat by +45.4% but stock -10.1%
EPS
$2.85
YoY +73%
Revenue
$1.0B
YoY +39%
Next-Q guidance
—
N/A
Price around earnings
Fell despite growthvs market -10.8%p4.7x normal — unusual drop+41% run-up before
Earnings trend · last 12 quarters
EPS$2.85YoY +73%
'23.9'26.6
Revenue$1.0BYoY +39%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
1x8%
Met expectations
good · up ↑
2x17%
Disappointment
weak · down ↓
0x
Good earnings ignored
good · down ↓
9x75%
← ← Weak earningsStrong earnings → →
Even on good earnings, the price often fell — earnings poorly reflected · 9 of 12q (75%)
Community · NBIX
What do you think of this stock's earnings pattern?
···